This early-phase study is testing a new radioactive tracer called 18F-αvβ6-BP to see if it can help doctors better locate cancer in the body. The tracer is given by IV, and then patients undergo several PET scans to see where it collects. The main goals are to check the safety of…
Phase: EARLY_PHASE1 • Sponsor: Julie L. Sutcliffe, Ph.D • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC